RYR2 and heart failure: The story is further complicated when we consider that there is controversy over the number of PKA phosphorylation sites and their associated functional effects on RyR2 gating, and perhaps more importantly, certain groups fail to observe any alteration in RyR2 phosphorylation at serine 2808/2809 in heart failure (51, 54).